Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams
This trial is active, not recruiting.
|Treatment||mri magnetic resonance imaging|
|Sponsor||University of Michigan|
|Start date||May 2011|
|End date||December 2018|
|Trial size||20 participants|
|Trial identifier||NCT00738712, HUM00041815|
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions.
|Intervention model||single group assignment|
New hardware or software technologies designed to improve MRI (Magnetic Resonance Imaging) exams.
Evaluation of new software in MRI vascular imaging
time frame: 1 year
Male or female participants at least 18 years old.
Inclusion Criteria: - male or non-pregnant female patient - 18 years or older - any ethnic background - presenting to MRI for a clinically-ordered chest MRI exam. Exclusion Criteria: - Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator. - Pregnant patients or patients who are lactating. - A patient who is claustrophobic
|Official title||Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams|
|Principal investigator||Hero Hussain, MD|
|Description||This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the vascular structures, abdomen, and pelvis regions. Software and hardware are always being improved, new machines replace old machines, software is updated and improved as well as devices used to produce better MRI images.|
Call for more information